Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 133 results for "biocon under kiran mazumdar shaw"

Pharma, biotech sectors over-regulated in India: Kiran Mazumda...

BIOCON CMD Kiran Mazumdar-Shaw's biography, Mythbreaker, by Seema Singh is also the story of Indian biotech. The book traces Mazumdar-Shaw's journey as an entrepreneur, her risk appetite and a fearless approach to all challenges she faced in her ... Financial Express, 1 week ago

14 images for biocon under kiran mazumdar shaw

Life Hacker India, 2 weeks ago
Indian Express, 2 weeks ago
Deccan Chronicle, 3 weeks ago
Times of India, 3 weeks ago
Weekly Voice, 2 weeks ago, 2 weeks ago
Deccan Chronicle, 3 weeks ago, 3 weeks ago
International Business Times India, 4 weeks ago
Bangalore Mirror, 3 weeks ago
Business Insider India

Biocon chief seeks five-year exemption from price control for pharma sector

Biocon chairperson Kiran Mazumdar-Shaw on Wednesday sought a five-year exemption from drug price control and asked the government to desist from ad hoc measures to help the pharmaceutical sector acquire scale and become competitive in the global ...
 Financial Express1 month ago Kiran Mazumdar seeks 5 year exemption from drug price control  Business Insider India1 month ago Reserve Bank of India To Stay On Hold Until 2016 End, Says Nomura  NDTV1 month ago Give exemption from drug price control for 5 yrs:Mazumdar-Shaw  Times of India1 month ago

Start-up frenzy reflects a herd-like mentality: Kiran Mazumdar-Shaw

India wasn't ready for a woman brewmaster in the 1970s when Kiran Mazumdar returned from Australia with a degree in brewing. No one was willing to take the risk of hiring a woman, not even United Breweries, where her father, Rasendra Mazumdar, had ...
 Smart Investor1 month ago

Kiran Mazumder-Shaw: A journey marked by grit

MYTH BREAKER KIRAN MAZUMDAR-SHAW AND THE STORY OF INDIAN BIOTECH Author: Seema Singh Publisher: HarperCollins Pages: 336 Price: Rs 599 When Unilever bought the Biocon Group [in 1989], it perhaps did not do enough 'due diligence' on the Indian ...
 Business Standard India1 month ago Standing her ground  Business Standard India1 month ago

Eight Indians in Asia's most powerful businesswomen list

The Forbes list includes Nita Ambani, Arundhati Bhattacharya, Chanda Kochhar and Kiran Mazumdar-Shaw, among others Mumbai: Power does not flow from executive titles. Nita Ambani would know it best. She's married to the richest Indian who heads the ...
 Livemint.com1 month ago Nita Ambani, SBI chief in Forbes power list  Hindu Business Line1 month ago India's Nita Ambani,...  Khaleej Times1 month ago Nita Ambani named most powerful businesswoman in Asia by Forbes [Mint, New Delhi]  Bloomberg1 month ago
International Business Times India

Biocon to develop oral insulin on its own after US drugmaker opts out of joint project

NotwithstandingU.S.-based pharma firm Bristol Myers Squibb (BMS) opting out of the joint project, Bengaluru-based biopharma company Biocon said on Tuesday that it would go ahead with the development of its oral insulin drug. A Biocon spokesperson ...
 International Business Times India1 week ago Biocon's biosimilars progress  Economic Times3 weeks ago Biocon in insulin pact  Calcutta Telegraph2 months ago Biocon to co-develop insulin for US market  ProKerala.com2 months ago

Mallya keen on returning to India; makes new settlement offer to SBI

Three weeks after Mumbai Mirror reported that Vijay Mallya's private jet underwent amakeover supervised by the Air India's engineers before its auction this month, it has now emerged that the plane's auction has been postponed to June 29-30 as only ...
 Equilibrio Informativo1 week ago Vijay Mallya tells UB board he has every intention of repaying loans  Livemint.com1 week ago Have every intention of repaying loans: Mallya reassures UB board  Hindustan Times1 week ago Vijay Mallya case: From arrest demand to suspension of passport, all you want to know  Financial Express1 month ago
Times of India

Biocon net up 79 percent in fourth quarter

Bengaluru, April 27 Biotech major Biocon Ltd. has posted consolidated net profit of Rs.361 crore for the fourth quarter (January-April) of fiscal 2015-16, registering a whopping 79 percent growth year-on-year (YoY) from Rs.201 crore in the like ...
 ProKerala.com3 weeks ago Landmark quarter for Biocon, net rises 79%  Hindu Business Line3 weeks ago Biocon expects more filings this year for biosimilars, drugs  Smart Investor3 weeks ago Biocon Earmarks Rs 268 Crore for Research After Inking Pact With Mexican Firm  New Indian Express3 weeks ago

Biocon, Mylan to challenge Delhi HC interim order on breast cancer drug

The order does not have material impact on the company as it was not prevented from selling the product, says Biocon Hyderabad: Biocon Ltd and its partner Mylan NV on Wednesday said they are going to challenge the Delhi high court interim order that ...
 Livemint.com3 weeks ago

Biocon SA inks pact with PiSA of Mexico

Biocon SA, the wholly-owned subsidiary of Biocon has entered into an agreement with Laboratorios PiSA S.A. de C.V (PiSA) of Mexico for the co-development and commercialisation of generic recombinant human insulin (rh-insulin) for the US market. The ...
 Deccan Herald2 months ago Biocon Enters Into Pact With Lab PiSA To Manufacture Rh-Insulin For US  NDTV2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon under kiran mazumdar shaw
Get updated on latest news & your favorite topics right in your inbox!
More     Less